Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline


Orion Genomics Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   25
ISBN Number   not applicable
Product Code   GMD735
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a Orion Genomics's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1.1 List Of Tables
  • 1.2 List of Figures
  • 2 Company Overview
  • 2.1 Key Information
  • 2.2 Financial Performance
  • 2.3 Industry Outlook - In Vitro Diagnostics
  • 3 Major Products and Services
  • 3.1 Overview
  • 4 Competitors
  • 5 Key Employees
  • 6 Locations And Subsidiaries
  • 6.1 Head Office
  • 7 Recent Developments
  • 7.1 Product News
    • 7.1.1 Jun 12, 2008: Local Company's Blood Test Could Identify Cancer Risk
    • 7.1.2 Dec 20, 2007: Orion Genomics Announces The Discovery Of Novel Breast Cancer Biomarkers
    • 7.1.3 Apr 14, 2007: Orion Genomics Announces The Discovery And Validation Of Biomarkers For Lung And Ovarian Cancer
    • 7.1.4 Apr 14, 2007: Orion Genomics Announces The Discovery And Validation Of Biomarkers For Lung And Ovarian Cancer
  • 7.2 Clinical Trials
    • 7.2.1 Jun 12, 2008: Local Company's Blood Test Could Identify Cancer Risk
  • 8 Orion Genomics Pipeline Products
  • 8.1 Orion Genomics Product Pipeline Analysis
    • 8.1.1 Orion Genomics Pipeline Products By Equipment Type
    • 8.1.2 Orion Genomics Pipeline Products By Development Stage
    • 8.1.3 Orion Genomics Pipeline Products By Therapy Area
    • 8.1.4 Orion Genomics Pipeline Products By News Summary
  • 8.2 Biomarker(breast cancer)
    • 8.2.1 Product Description
    • 8.2.2 Product Status
    • 8.2.3 Product Milestone
  • 8.3 Biomarker-lung cancer
    • 8.3.1 Product Description
    • 8.3.2 Product Institution Details
    • 8.3.3 Product Status
    • 8.3.4 Product Milestone
  • 8.4 Biomarker(ovarian cancer)
    • 8.4.1 Product Description
    • 8.4.2 Product Status
    • 8.4.3 Product Milestone
  • 8.5 Orion Colorectal Cancer Risk Test
    • 8.5.1 Product Description
    • 8.5.2 Product Status
    • 8.5.3 Product Milestone
  • 9 Appendix
  • 9.1 Methodology
    • 9.1.1 Coverage
    • 9.1.2 Secondary Research
    • 9.1.3 Primary Research
    • 9.1.4 Expert Panel Validation
  • 9.2 Contact Us
  • 9.3 About Global Markets Direct
  • 9.4 Disclaimer
  • 1.1 List Of Tables
  • Table 1: Orion Genomics,Key Facts
  • Table 2: Orion Genomics, Key Employees,
  • Table 3: Orion Genomics Pipeline Products by Equipment Type
  • Table 4: Orion Genomics Pipeline Products By Development Stage
  • Table 5: Orion Genomics Pipeline Products By Therapy Area
  • Table 6: Orion Genomics Pipeline Products By News Summaries
  • 1.2 List of Figures
  • Figure 1: Orion Genomics Pipeline Products By Development Stage
  • Figure 2: Global Markets Direct Methodology